Osteoarthritis Flashcards

1
Q

Men tend to have OA in the ____. Women tend to have OA in the _____.

A

Men: hips. Women: proximal and distal interphalangeal joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are Bouchards Nodes, Herberdens Nodes

A

Bouchards: bone spur in PIP
Herberdens: bone spur in DIP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Localized OA involves ____ sites.

A

1 or 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Generalized OA involves ____ sites.

A

3 or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Primary OA?

A

Results from normal aging changes, erosive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Secondary OA?

A

Results from traumatic injury or inherited conditions. RA, chronic gouty arthritis, infectious arthritis. Hemochromatosis, Wilsons disease, Pagets disease. DM, obesity, hormone abnormailities. Steroid overuse, bone dysplasia. Basically anything not associated withnormal agin changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define OA

A

Slow, progressive disorder affecting primarily weight bearing joints. Progressive deterioration and loss of articular cartilage, with formation of new bone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

OA Rx therapy, first line

A

Tylenol325-650mg q4hr or 1000mg q6hr, max 4g daily. Must renal/heaptic adjust. Max for ETOH use is 2g/day. Inhibits COX. 4-6 weeks trial is sufficient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

OA Rx therapy, second line

A

NSAIDs. Inhibits COX1, COX2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COX 1 is located where?

A

GI tract, kidneys. Produces thromboxane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Patho of OA:

A

Normal cartilage is supported by subchondral bone. Deterioration of cartilage diffuses stress to the bone, bone responds by remodling. This new bone is thicker and if remodling occurs at joint- a bone spur can form. Decreased cartilage + decreased synovial fluid production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dx of OA

A

sinovial fluid is of higher viscosity. Pt SS, crepidus, deformity of joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

OA Rx therapy, first line

A

Tylenol 325-650mg q4hr or 1000mg q6hr, max 4g daily. Must renal/heaptic adjust. Max for ETOH use is 2g/day. Inhibits COX. 4-6 weeks trial is sufficient.
dose of 1300mg > d chronic use can increase INR if pt on Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

OA Rx therapy, second line

A

NSAIDs. Inhibits COX1, COX2.
NSAIDs require 5 half lives to be therapeutic, 5 half lives to be fully excreted. Longer half life needs longer periods to be therapeutic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aspirin

A

325-650mg q4-6hr, Max dose 3600mg/day. Monitor seum for >3g/day.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Salsalate

A

500-1000mg bid-tid, max 3000mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Etodolac

A

200-400mg bid-tid IR or 400-1200mg daily. Max 1200mg

18
Q

Dicolfenac PO

A

50mg bid-tid, 75mg bid or 100-200mg daily, XR

Max dose 150mg

19
Q

Indomethacin

A

25-50mg tid, 75 mg once - bid, max 200mg day

20
Q

Nabumentone

A

500-1000mg daily, bid. Max dose 2000mg

21
Q

Ibuprofen

A

400-800mg tid-qid, Max 3200mg/day

22
Q

Naproxen

A

Controlled release: 250-500mg BID or 750-1000mg/d Max 1650mg

Naproxen Sodium 275-500mg BID max 1650mg/d

23
Q

Meloxicam

A

705-15mg daily Max 15mg

24
Q

Prioxicam

A

20mg PO daily

25
Q

Ketoprofen

A

25-75mg tid-qid, 100-200mg XR day

26
Q

Tramadol

A

Low potential for abuse compared to opioids. Risk of seizure is dose dependent and increased with antidepressant use- seratonin syndrome. Avoid with MAOIs
50-100mg q4-6hr, max 400mg. Elderly dosing is max 300mg
ER- 100-300mg daily
GFR <30- 50-100mg q12h, max dose 200mg

27
Q

Tapentadol (nucynta, nucynta er)

A

agonist for mu receptor, no effect on inflammation.
IR 50-100mg q4-6 hr max 600mg
ER 50-250 PO bid

28
Q

Glucosamine and Condroitin

A

Glucosamine is thought to be a chondroprotective, stimulating cartilage matrix.
Chondroitin is thought to inhibit degradative enzymes
Caution with shellfish allergies AND DIABETICS- MAY ELEVATE BG levels
Glucosamine 500mg tid or 1500mg daily
Chondroitin 400-800mg tid with glucosamine

29
Q

Hyaluronan

A

weekly injections for 3-5 weeks, provides longer pain relief compared to steroids

30
Q

Corticosteroids

A

Works with inflammatory component or knee effusion involving 1-2 joints. Should not be injected more than 3-5 times a year. Works quicker than HA

31
Q

Capsacian Topical

A

apply every 6-8h, max effect seen after 2-4 weeks of consistent use.

32
Q

Diclofenac gel

A

Only 6-10 percent of gel and 2-3 percent of lotion is absorbed.

33
Q

OA- caution with elderly

A

choose nsaid with a shorter half life

caution with GI risk and COX1, need to have a gastric protective as well.

34
Q

OA and pregnancy

A

caution with NSAID- increased risk of bleeding. Ibuprofen and Naproxen Cat B in 1-2 trimester
All NSAIDs are contraindicated in 3rd trimester

35
Q

Varus vs. Valgus

A

Varus: bow legged
Valgus: knock kneed

36
Q

Radiologic findings of OA

A

narrow joint spaces, bone spurs

37
Q

OA in cervical spine

A

can radiate to traps, cervical area, nerve involvement

38
Q

OA in lumbar

A

produces symptoms of neurogenic claudication

39
Q

OA in hip

A

gate disturbances

40
Q

NSAIDS with GI issues should also be given

A

PPI or misoprostol

41
Q

NSAIDS plus ACEi can cause

A

decreased renal function

42
Q

ibuprofen and ASA

A

ibuprofen is to be taken 8hr before or 30min-2hr after ASA for ASA to be cardio effective